Skip to main content

Table 1 Symptoms leading to referral for [18F]FDG-PET/CT in 225 women suspected of recurrent breast cancer

From: Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study

Symptoms

All patients

Metastatic breast cancer

n (%)

n (%)

Bone pain

90 (40.0)

24 (46.2)

Local recurrence examination

45 (20.0)

9 (17.3)

Fatigue

33 (14.7)

5 (9.62)

Weight loss

27 (11.9)

1 (1.92)

Abnormal blood test

25 (11.1)

5 (9.62)

Abdominal discomfort

23 (10.2)

7 (13.5)

Palpable lymph node

16 (7.11)

7 (13.5)

Shortness of breath

11 (4.89)

6 (11.5)

Changes in skin

7 (3.11)

3 (5.77)

Nausea and/or vomiting

7 (3.11)

0 (0.00)

Other

90 (40.0)

12 (23.1)

Total

225 (100)

52 (100)

  1. Elevated liver enzymes, anemia, or other blood tests
  2. Pain elsewhere, headache, medullary stress, pleural fluid, detected randomly in radiologic tests, or other symptoms